ANDA 70052, held by Pharmazone. Betamethasone Valerate.
As of Nov 15, 2026, ANDA 70052 (Betamethasone Valerate), held by Pharmazone, was first approved by FDA on Jul 31, 1985, with 11 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jul 31, 1985 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Betamethasone ValerateEQ 0.1% BASE ยท lotion;topical | Betamethasone Valerate | Rx |
| Mar 5, 1992 | Supplement 9Labeling | Approved | None posted |
| Sep 3, 1991 | Supplement 10Manufacturing | Approved | None posted |
| Aug 2, 1991 | Supplement 11Manufacturing | Approved | None posted |
| Aug 2, 1991 | Supplement 12Manufacturing | Approved | None posted |
| Aug 2, 1991 | Supplement 13Manufacturing | Approved | None posted |
| Oct 13, 1989 | Supplement 8Labeling | Approved | None posted |
| Feb 15, 1989 | Supplement 5Manufacturing | Approved | None posted |
| Feb 15, 1989 | Supplement 6Manufacturing | Approved | None posted |
| Feb 15, 1989 | Supplement 7Manufacturing | Approved | None posted |
| Dec 2, 1987 | Supplement 4Manufacturing | Approved | None posted |
| Oct 9, 1986 | Supplement 2Manufacturing | Approved | None posted |
| Jul 31, 1985 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters